this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Conferences & Events
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
National Issues
• Health Care
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance


Thursday, July 24, 2008

Health Care | Comparative Effectiveness

Click here for a printer-friendly page Printer Friendly

Comparative Effectiveness

Supporting Patient-Centered Care to Improve Health Outcomes

As a representative of an industry committed to discovering new cures and ensuring patient access to them, BIO strongly supports efforts to increase the availability of accurate, scientific evidence to inform clinical decision-making. BIO believes that individual patients and their doctors should be armed with the best available information to help assess the relative clinical benefits and risks of various treatment alternatives. When appropriately applied, comparative effectiveness information is a valuable tool that, together with a variety of other types of medical evidence, can contribute to improving health care delivery. However, BIO is concerned that comparative effectiveness information may be used strictly as a means to contain costs, rather than deliver health care value by improving patient health outcomes.

BIO Principles on Comparative Effectiveness
Read BIO's Principles on Comparative Effectiveness Research

The Complexities of Comparative Effectiveness
Read BIO's White Paper on Comparative Effectiveness

BIO's comments to AHRQ regarding the Guide to Conducting Comparative Effectiveness Reviews (November 7, 2007)
Read the comments (208 KB PDF)

© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024